The DOI matches its Crossref record; 221 of the 221 references it cites were found in a registry or an index.
Nanocarrier-based systems for targeted and site specific therapeutic delivery
Open accessAbstract
Systemic drug delivery methods such as oral or parenteral administration of free drugs possess relatively low treatment efficiency and marked adverse side effects. The use of nanoparticles for drug delivery in most cases substantially enhances drug efficacy, improves pharmacokinetics and drug release and limits their side effects. However, further enhancement in drug efficacy and significant limitation of adverse side effects can be achieved by specific targeting of nanocarrier-based delivery systems especially in combination with local administration. The present review describes major advantages and limitations of organic and inorganic nanocarriers or living cell-based drug and nucleic acid delivery systems. Among these, different nanoparticles, supramolecular gels, therapeutic cells as living drug carriers etc. have emerged as a new frontier in modern medicine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–221 of 221
Sahle, F. F., Metz, H., Wohlrab, J., & Neubert, R. H. H. (2012) · Pharmaceutical Research · doi:10.1007/s11095-012-0899-x · Cited by 38
Majumder, J., Das, M., Deb, J., Jana, S. S., & Dastidar, P. (2013) · Langmuir · doi:10.1021/la401929v · Cited by 37
Self-citationSchumann, C., Chan, S., Khalimonchuk, O., Khal, S., Moskal, V., Shah, V. M., Alani, A. W. G., Taratula, O. R., & Taratula, O. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00205 · Cited by 36
Self-citationCell-mediated drug delivery to the brain
Batrakova, E. V., & Kabanov, A. V. (2013) · Journal of Drug Delivery Science and Technology · doi:10.1016/s1773-2247(13)50061-x · Cited by 32
Marcucci, F., Caserta, C. A., Romeo, E. L., & Rumio, C. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00167 · Cited by 32
Kunath, K., Kopečková, P., Minko, T., & Kopec̆ek, J. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(99)00033-8 · Cited by 31
Self-citationLung cancer: active therapeutic targeting and inhalational nanoproduct design
Alhajj, N., Chee, C. F., Wong, T. W., Rahman, N. A., Kasim, N. H. A., & Colombo, P. (2018) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2018.1547280 · Cited by 31
Schumann, C., Chan, S., Millar, J. A., Bortnyak, Y., Carey, K., Fedchyk, A., Wong, L., Korzun, T., Moses, A. S., Lorenz, A. S., et al. (2018) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2018.03.005 · Cited by 30
Self-citationHong, D. I., & Sloane, D. E. (2019) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2019.04.015 · Cited by 28
Directed apoptosis in Cox-2-overexpressing cancer cells through expression-targeted gene delivery
Godbey, W. T., & Atala, A. (2003) · Gene Therapy · doi:10.1038/sj.gt.3302012 · Cited by 25
Fercher, C., Keshvari, S., McGuckin, M. A., & Barnard, R. T. (2017) · Experimental Biology and Medicine · doi:10.1177/1535370217748575 · Cited by 24
Peptide Sequence-Dominated Enzyme-Responsive Nanoplatform for Anticancer Drug Delivery
Li, Y., Du, L., Wu, C., Yu, B., Zhang, H., & An, F. (2019) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026619666190125144621 · Cited by 21
Takayama, Y., Kusamori, K., Hayashi, M., Tanabe, N., Matsuura, S., Tsujimura, M., Katsumi, H., Sakane, T., Nishikawa, M., & Yamamoto, A. (2017) · Scientific Reports · doi:10.1038/s41598-017-17166-8 · Cited by 20
Zhang, L., Jiao, T., Ma, K., Xing, R., Liu, Y., Xiao, Y., Zhou, J., Zhang, Q., & Peng, Q. (2016) · Materials · doi:10.3390/ma9070541 · Cited by 18
Peptide receptors as cancer drug targets
Moody, T. W. (2019) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14100 · Cited by 18
Patil, S. P., Kim, S., Jadhav, J. R., Lee, J.-H., Jeon, E. M., Kim, K., & Kim, B. H. (2014) · Bioconjugate Chemistry · doi:10.1021/bc500249g · Cited by 17
Roy, R., Bhagyalalitha, M., Choudhury, P., & Dastidar, P. (2016) · Chemical Communications · doi:10.1039/c6cc07712a · Cited by 15
The Resistive Switching Characteristics in ZrO2 and Its Filamentary Conduction Behavior
Lai, C., Chen, H.-W., & Liu, C. (2016) · Materials · doi:10.3390/ma9070551 · Cited by 12
Targeted immunotherapy of cancer: development of antibody-induced cellular immunity
Lu, Y. J., & Low, P. S. (2003) · Journal of Pharmacy and Pharmacology · doi:10.1211/002235702540 · Cited by 11
Li, Y., Weifan, Y., & Yang, H. (2019) · Cytotherapy · doi:10.1016/j.jcyt.2019.04.060 · Cited by 10
Ultrasound Activated Nano-Encapsulated Targeted Drug Delivery and Tumour Cell Poration
Gourevich, D., Gerold, B., Arditti, F. D., Xu, D., Liu, D., Volovick, A., Wang, L., Medan, Y., Gnaïm, J., Prentice, P., et al. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-2555-3_13 · Cited by 8
Cited by
Stimuli-Responsive Polymeric Nanocarriers for Drug Delivery, Imaging, and Theragnosis
Das, S. S., Bharadwaj, P., Bilal, M., Barani, M., Rahdar, A., Taboada, P., Bungau, S., & Kyzas, G. Z. (2020) · Polymers · doi:10.3390/polym12061397 · Cited by 581
Alshawwa, S. Z., Kassem, A. A., Farid, R. M., Mostafa, S. K., & Labib, G. S. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14040883 · Cited by 531
Recent Developments on Therapeutic and Diagnostic Approaches for COVID-19
Majumder, J., & Minko, T. (2021) · The AAPS Journal · doi:10.1208/s12248-020-00532-2 · Cited by 505
Self-citationNanoparticles in Drug Delivery: From History to Therapeutic Applications
Afzal, O., Altamimi, A. S. A., Nadeem, M. S., Alzarea, S. I., Almalki, W. H., Tariq, A., Mubeen, B., Murtaza, B. N., Iftikhar, S., Riaz, N., et al. (2022) · Nanomaterials · doi:10.3390/nano12244494 · Cited by 468
Recent progress in nanomedicine for enhanced cancer chemotherapy
Wei, G., Wang, Y., Yang, G., Wang, Y., & Ju, R. (2021) · Theranostics · doi:10.7150/thno.57828 · Cited by 463
Metadata
- Authors
- Majumder, J., Taratula, O., & Minko, T.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2019-04
- Volume
- 144
- Pages
- 57-77
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W2966612446
- Cited by
- 394
- References
- 221
- FWCI
- 1.86
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.